Titre : | Males and females differ in response to opioid agonist medications |
Titre traduit : | (Hommes et femmes diffèrent dans leur réponse aux traitements antagonistes opiacés) |
Auteurs : | H. E. JONES ; H. FITZGERALD ; R. E. JOHNSON |
Type de document : | Périodique |
Année de publication : | 2005 |
Format : | 223-233 / tabl. |
Note générale : |
American Journal on Addictions, 2005, 14, (3), 223-233 |
Langues: | Anglais |
Discipline : | TRA (Traitement et prise en charge / Treatment and care) |
Mots-clés : |
Thésaurus mots-clés SEXE ; ANTAGONISTE ; OPIACES ; PHARMACOTHERAPIE ; COMPARAISON ; EFFICACITE ; RETENTION ; OBSERVANCE DU TRAITEMENT |
Résumé : |
ENGLISH : Few clinical trials include sex as a factor. This analysis explored within-sex differences in response to opioid agonist medications. Males and females randomly assigned to buprenorphine, LAAM, or methadone were compared on opioid use and retention in treatment. Females receiving buprenorphine had less objective drug use than females receiving methadone, while males receiving LAAM had less objective drug use than males receiving buprenorphine. Retention in treatment was longer for both sexes receiving methadone versus LAAM. Within-subject change results indicate that all three medications benefit both sexes. Clinical trials should be designed to examine the impact of sex on outcomes. (Review' s abstract) |
Note de contenu : | tabl. |
Domaine : | Drogues illicites / Illicit drugs |
Refs biblio. : | 47 |
Affiliation : |
Center for Addiction and Pregnancy, D-3 East, Johns Hopkins Bayview Medical Center, 4940 Eastern Av., Baltimore, MD 21224 ; hendreejonesyahoo.com Etats-Unis. United States. |
Numéro Toxibase : | 208258 |
Centre Emetteur : | 02 Coordonnateur |
Exemplaires
Disponibilité |
---|
aucun exemplaire |
Accueil